Lymphoma Steering Committee

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

The NCI Lymphoma Steering Committee (LYSC) was established in 2009. At monthly meetings, it addresses the design, prioritization, and evaluation of concepts for phase II and phase III clinical trials in adult lymphoma. View the LYSC member roster.

Strategic Priorities

  • LYSC Strategic Priorities were formulated with the goal that the majority of submitted concepts would align with the established priorities. They address areas of unmet clinical need, important unanswered clinical questions, and potential new approaches to disease treatment.

Clinical Trials Planning Meetings (CTPMs)

CTPMs are held periodically and focus on specific clinical trial related topics. The following are important LYSC CTPMs:

  • Lymphoma - November 2014
    A CTPM was organized to discuss current understanding of the major lymphoma subtypes, to identify unmet needs in the treatment of those diseases, and chart the clinical research agenda in lymphoma for the next five years.
  • B-Cell Lymphoma (DLBCL) Working Group
    In October 2010, a CTPM was held to explore clinical trials in DLBCL. Read the executive summary.


For more information, contact Lawrence Baizer, Ph.D. at

  • Updated: December 14, 2016